195 related articles for article (PubMed ID: 17409627)
1. Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.
Takayasu Y; Nakaki J; Kawasaki T; Koda K; Ago Y; Baba A; Matsuda T
J Pharmacol Sci; 2007 Apr; 103(4):434-7. PubMed ID: 17409627
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action.
Tian J; Li G; Liu Z; Fu F
Pharmacology; 2008; 82(2):121-6. PubMed ID: 18583922
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression.
Rajesh KG; Sasaguri S; Suzuki R; Maeda H
Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2171-8. PubMed ID: 12816747
[TBL] [Abstract][Full Text] [Related]
4. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis.
Xi H; Akishita M; Nagai K; Yu W; Hasegawa H; Eto M; Kozaki K; Toba K
Atherosclerosis; 2007 Apr; 191(2):281-9. PubMed ID: 16806227
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with edaravone reduces lung mitochondrial damage in an infant rabbit ischemia-reperfusion model.
Qiu W; Gu H; Zheng L; Zhou J; Chen D; Chen Y
J Pediatr Surg; 2008 Nov; 43(11):2053-60. PubMed ID: 18970940
[TBL] [Abstract][Full Text] [Related]
6. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
7. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
[TBL] [Abstract][Full Text] [Related]
8. 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain.
Tian J; Zhang S; Li G; Liu Z; Xu B
Phytother Res; 2009 Apr; 23(4):486-91. PubMed ID: 19003949
[TBL] [Abstract][Full Text] [Related]
9. Effects of edaravone on experimental brain injury in view of free radical reaction.
Nakamura H; Uzura M; Uchida K; Nakayama H; Furuya Y; Hayashi T; Sekino H; Ominato M; Owada S
Acta Neurochir Suppl; 2003; 86():309-11. PubMed ID: 14753459
[TBL] [Abstract][Full Text] [Related]
10. Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway.
Chen H; Wang S; Ding JH; Hu G
J Neurochem; 2008 Sep; 106(6):2345-52. PubMed ID: 18643790
[TBL] [Abstract][Full Text] [Related]
11. Effects of edaravone on human neutrophil function.
Mikawa K; Akamatsu H; Nishina K; Obara H; Niwa Y
Acta Anaesthesiol Scand; 2005 Mar; 49(3):385-9. PubMed ID: 15752406
[TBL] [Abstract][Full Text] [Related]
12. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
Morimoto K; Hasegawa T; Tanaka A; Wulan B; Yu J; Morimoto N; Okita Y; Okada K
J Vasc Surg; 2012 Jun; 55(6):1749-58. PubMed ID: 22341578
[TBL] [Abstract][Full Text] [Related]
13. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver.
Okatani Y; Wakatsuki A; Enzan H; Miyahara Y
Eur J Pharmacol; 2003 Mar; 465(1-2):163-70. PubMed ID: 12650846
[TBL] [Abstract][Full Text] [Related]
14. Edaravone ameliorates compression-induced damage in rat nucleus pulposus cells.
Lin H; Ma X; Wang BC; Zhao L; Liu JX; Pu FF; Hu YQ; Hu HZ; Shao ZW
Life Sci; 2017 Nov; 189():76-83. PubMed ID: 28942283
[TBL] [Abstract][Full Text] [Related]
15. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
Yagi K; Kitazato KT; Uno M; Tada Y; Kinouchi T; Shimada K; Nagahiro S
Stroke; 2009 Feb; 40(2):626-31. PubMed ID: 19095969
[TBL] [Abstract][Full Text] [Related]
16. Maternal treatment with MCI-186 does not improve delayed deterioration of cellular bioenergetic state and mitochondrial activity following transient intrauterine ischemia in the fetal rat brain.
Yokota A; Nakai A; Taniuchi Y; Okuda N; Nakai M; Takeshita T
J Nippon Med Sch; 2005 Apr; 72(2):127-30. PubMed ID: 15940021
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of the free radical scavenger edaravone against glutamate neurotoxicity in nearly pure neuronal culture.
Hisano K; Watanabe M; Morimoto Y
J Anesth; 2009; 23(3):363-9. PubMed ID: 19685116
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis.
Liu L; Song Y; Zhao M; Yi Z; Zeng Q
Int Urol Nephrol; 2015 Oct; 47(10):1745-52. PubMed ID: 26300162
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes.
Yamawaki M; Sasaki N; Shimoyama M; Miake J; Ogino K; Igawa O; Tajima F; Shigemasa C; Hisatome I
Br J Pharmacol; 2004 Jun; 142(3):618-26. PubMed ID: 15148265
[TBL] [Abstract][Full Text] [Related]
20. Improvement of postischemic dopaminergic dysfunction by edaravone, a free radical scavenger.
Akiyama Y; Miwa S
J Pharmacol Sci; 2007 May; 104(1):99-102. PubMed ID: 17452805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
